Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Risk factors for ...
New research identifies age, anti-β2GP1 antibodies, and low complement C3 as key risk factors for cerebral small vessel ...
Certain autoantibodies were significantly associated with neuropsychiatric manifestations of systemic lupus erythematosus, emphasizing their utility for accurately diagnosing and managing this complex ...
Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...
Objective To characterise the age-related impact of organ damage patterns on health-related quality of life (HRQoL) in ...
In a new study, researchers identify biomarkers that may predict the efficacy of low-dose IL-2 (Ld-IL2) treatment in people with systemic lupus erythematosus (SLE). IL-2 stands for interleukin-2 – a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback